Literature DB >> 30317540

The competing endogenous circular RNA ADAMTS14 suppressed hepatocellular carcinoma progression through regulating microRNA-572/regulator of calcineurin 1.

Changlong Song1, Dianqiu Li2, Hongyu Liu3, Hongyan Sun4, Zhen Liu5, Lirong Zhang4, Yu Hu4.   

Abstract

Emerging evidence have discovered that circular RNAs (circRNAs) may serve as diagnostic or tumor promising biomarkers. This study aimed to investigate how circular RNA ADAMTS14 (circADAMTS14) regulates microRNA-572/ regulator of calcineurin 1(miR-572/ RCAN1) in hepatocellular carcinoma (HCC). The expression profiles of circRNA/microRNA (mRNA) between HCC tissues and paired adjacent tissues were analyzed via microarray analysis. The expressions of circADAMTS14, miR-572, and RCAN1 were measured by real-time polymerase chain reaction (PCR). The protein expression level of RCAN1 in HCC cells was detected by western blot. The viability and apoptosis levels of HCC cell lines were measured by the cell counting Kit-8 (CCK-8) assay and fluorescence-activated cell sorter. The invasiveness and migration of cells were detected based on the transwell and wound-healing assay, respectively. The dual-luciferase reporter assays were used to reveal circADAMTS14 and RCAN1 as a potential target of miR-572, which was predicted by TargetScan and miRBase. The effect of circADAMTS14 on HCC cells was demonstrated by tumor formation in nude mice in vivo. CircADAMTS14 and RCAN1 were lowly expressed in HCC clinical specimens and cell lines using microarrays and qRT-PCR, but miR-572 inversely. Our study further verified the direct interaction between circADAMTS14 and RCAN1 with miR-572 via the dual-luciferase reporter gene assay. Overexpressed circADAMTS14 and RCAN1 induced apoptosis of HCC cells and inhibited cell proliferation and invasion. But overexpressed miR-572 could decrease apoptosis of HCC cells and promote proliferation and invasion. In vivo, circADAMTS14 inhibited the tumor growth, correlated positively with the protein expression levels of RCAN1. Our results demonstrated that circADAMTS14 might suppress HCC progression through regulating miR-572/ RCAN1 as the competing endogenous RNA.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  RCAN1; circular RNAs ADAMTS14 (circADAMTS14); hepatocellular carcinoma (HCC); miR-572

Mesh:

Substances:

Year:  2018        PMID: 30317540     DOI: 10.1002/jcp.26764

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  17 in total

Review 1.  The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.

Authors:  Dexter L Puckett; Mohammed Alquraishi; Winyoo Chowanadisai; Ahmed Bettaieb
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

Review 2.  Circular RNA as a Novel Biomarker and Therapeutic Target for HCC.

Authors:  Hongwu Meng; Ruowen Niu; Cheng Huang; Jun Li
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

Review 3.  RCAN1-mediated calcineurin inhibition as a target for cancer therapy.

Authors:  Mengyi Lao; Xiaozhen Zhang; Hanshen Yang; Xueli Bai; Tingbo Liang
Journal:  Mol Med       Date:  2022-06-18       Impact factor: 6.376

4.  Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients.

Authors:  Chong Shen; Zhouliang Wu; Yujie Wang; Shen Gao; Linguo Xie; Yunkai Qie; Dawei Tian; Hailong Hu
Journal:  Cancer Med       Date:  2020-04-06       Impact factor: 4.452

Review 5.  Emerging roles of circRNA in formation and progression of cancer.

Authors:  Yuting Yin; Jiali Long; Qinglian He; Yuling Li; Yanqiu Liao; Peishan He; Wei Zhu
Journal:  J Cancer       Date:  2019-08-28       Impact factor: 4.207

Review 6.  Tumor-suppressive circular RNAs: Mechanisms underlying their suppression of tumor occurrence and use as therapeutic targets.

Authors:  Zhe Li; Yao Ruan; Haiyan Zhang; Yijing Shen; Tianwen Li; Bingxiu Xiao
Journal:  Cancer Sci       Date:  2019-10-25       Impact factor: 6.716

7.  MicroRNA-572/hMOF/Sirt6 regulates the progression of ovarian cancer.

Authors:  Mingbo Cai; Zhenhua Hu; Liping Han; Ruixia Guo
Journal:  Cell Cycle       Date:  2020-08-23       Impact factor: 4.534

Review 8.  Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma.

Authors:  Jin-Yu Sun; Xiao-Yu Zhang; Yi-Zhi Cao; Xiao Zhou; Jian Gu; Xiao-Xin Mu
Journal:  J Cell Mol Med       Date:  2020-04-13       Impact factor: 5.310

9.  Comprehensive circular RNA profiling reveals the regulatory role of the hsa_circ_0137606/miR‑1231 pathway in bladder cancer progression.

Authors:  Weijian Li; Youjian Li; Zhongxu Sun; Jun Zhou; Yuepeng Cao; Wenliang Ma; Kaipeng Xie; Xiang Yan
Journal:  Int J Mol Med       Date:  2019-09-17       Impact factor: 4.101

Review 10.  Circular RNA is a popular molecule in tumors of the digestive system (Review).

Authors:  Hao-Ying Wang; Yu-Ping Wang; Xi Zeng; Ya Zheng; Qing-Hong Guo; Rui Ji; Yong-Ning Zhou
Journal:  Int J Oncol       Date:  2020-04-27       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.